Christopher J Coughlin insider trades

Open-market stock purchases and sales by Christopher J Coughlin, Director at Centene Corp, from SEC Form 4 filings since Feb 11, 2010.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -5%.

Recent trades

DateStockTradeValue
Sep 30, 2026CNC Centene CorpBought (not open market)—
Jun 30, 2026CNC Centene CorpBought (not open market)—
May 12, 2026CNC Centene CorpBought (not open market)—
Mar 31, 2026CNC Centene CorpBought (not open market)—
Dec 31, 2025CNC Centene CorpBought (not open market)—

Companies traded

  • CNC Centene Corp: 2 buys, 1 sale, last Sep 30, 2026
  • KRTX Karuna Therapeutics, Inc: other filings, last Mar 18, 2024
  • PBH Prestige Consumer HealthCare Inc: other filings, last Aug 2, 2022
  • ALXN Alexion Pharmaceuticals, Inc: 2 buys, last Jul 21, 2021
  • AGN Allergan plc: 14 buys, last May 8, 2020
  • DNB DUN & Bradstreet Corp/nw: 2 sales, last Mar 10, 2017
  • HOLX Hologic Inc: other filings, last Mar 8, 2017
  • ACT Actavis plc: other filings, last Jun 5, 2015
  • COV Covidien plc: 1 sale, last Jan 26, 2015
  • FRX Forest Laboratories, LLC: other filings, last Jul 1, 2014
  • DPRX Dipexium Pharmaceuticals, Inc: 1 buy, last Mar 18, 2014
  • TYC Tyco International Ltd: other filings, last Nov 26, 2010

Get free alerts when Christopher J Coughlin files a new trade →